More European Countries Temporarily Suspend Use of AstraZeneca Vaccine

Friday, 12 March 2021 05:45

By Canadian Press

Health officials investigating whether vaccine causes blood clots

Health Canada is keeping tabs on European investigations into the Oxford-AstraZeneca vaccine after overseas reports of some recipients developing blood clots following inoculations.

For now, the government agency is assuring Canadians that the ''benefits of the vaccine continue to outweigh its risks.''

It says it authorized the vaccine for Canadian use based on a thorough review.

At least nine European countries as well as, Thailand, have temporarily suspended their use of AstraZeneca's doses pending investigation of blood clots, though none suggest there is a link between the two.

More from Local News

Province Investing Against Invasive Species

The $2-million will help the Niagara region
Niagara Driver Charged with Drug Impairment

OPP say this happened on Highway 17, when a car was seen weaving all over the road
Welland Man Arrested for Child Porn

Police say they noticed child sexual abuse material shared on a social media page early this month
28 More Doctors Hired in Niagara

The region and Niagara Health coordinating new partnership to find even more doctors
Killed Police Officers Honoured by NRP

Police Chief praised Niagara members for standing at attention in 'pounding rain'
Niagara Wineries Shuttle Service Possible

The CUTRIC hopes the province supports helping people move among wineries
Canal Days Vendors Warned of Scams

The City of Port Colborne says criminals are sending fraud emails for payment
Niagara Falls Exploring Hub to Help Homeless

Former CAO Ken Todd has been meeting with community groups

More European Countries Temporarily Suspend Use of AstraZeneca Vaccine

Share

More from Local News